Policymakers must work with insurers and GLP-1 manufacturers to make sure these life-changing therapies remain accessible. Blanket denials of coverage will harm patients, invite long-term costs, and worsen the stigma we should be fighting against.
gic
Posted inThe Codcast
Why a quasi-independent state agency needed a quick $240 million
John McDonough, Paul Hattis, and Matt Veno of the Group Insurance Commission discuss the GIC’s last-minute $240 million infusion from state coffers to cover claims for the rest of the 2025 fiscal year.
